13F filer · CIK 1273087 ↗
Millennium Management
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$64.13B
−21% on the quarter before
Positions
3,693
719 new · 866 sold out
Top 10
6.7%
of the value
Est. gain
−$7.52B
on stocks held all quarter
Est. return
−17.0%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Millennium Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 13% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Starbucks Corp~$381.7MAdded · 0.0% → 0.6%+5,926,793 shares
- Celgene Corp~$328.7MAdded · 0.1% → 0.6%+5,129,102 shares
- Tesla~$260.7MAdded · 0.0% → 0.4%+783,209 shares
- Bristol Myers Squibb Co~$254.2MAdded · 0.2% → 0.6%+4,890,444 shares
- Intel~$246.5MAdded · 0.0% → 0.4%+5,251,782 shares
- Booking Hldgs Inc~$236.7MAdded · 0.0% → 0.4%+137,412 shares
- Oracle~$233.0MAdded · 0.3% → 0.7%+5,160,700 shares
- Mastercard~$230.1MAdded · 0.0% → 0.4%+1,219,620 shares
- Anadarko Pete Corp~$223.4MAdded · 0.0% → 0.4%+5,095,016 shares
- Cvs Health Corp~$216.5MAdded · 0.1% → 0.4%+3,303,892 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrCALL~$1.49BCut · 2.3% → 0.2%−5,964,600 underlying
- Fortive Corp~$1.15BCut · 1.8% → 0.0%−17,003,025 shares
- Andeavor~$1.11BSold out · 1.4% → 0.0%−7,205,863 shares
- Aetna Inc New~$534.9MSold out · 0.7% → 0.0%−2,636,738 shares
- Fortive CorpPUT~$404.2MSold out · 0.5% → 0.0%−4,800,000 underlying
- Ishares TrPUT~$402.3MSold out · 0.5% → 0.0%−3,500,000 underlying
- Ishares TrPUT~$378.5MCut · 0.5% → 0.0%−4,666,000 underlying
- Microsoft~$331.4MCut · 0.6% → 0.1%−3,263,218 shares
- Amazon~$262.0MCut · 0.8% → 0.3%−174,405 shares
- Pinnacle Foods Inc Del~$250.2MSold out · 0.3% → 0.0%−3,861,278 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Altaba IncCOM · shares −2.1% · price −14.9% | 1.1% | $673.9M | −$118.4M | ||||||||
| AppleCOM · shares −8.1% · price −30.1% | 0.81% | $517.4M | −$223.1M | ||||||||
| OracleCOM · shares +106% · price −12.4% | 0.71% | $453.8M | −$31.4M | ||||||||
| QualcommCOM · shares +43% · price −21.0% | 0.63% | $401.7M | −$74.6M | ||||||||
| Starbucks CorpCOM · shares +4,572% · price +13.3% | 0.61% | $390.0M | +$979,465 | ||||||||
| Celgene CorpCOM · shares +631% · price −28.4% | 0.59% | $380.8M | −$20.7M | ||||||||
| Merck & Co IncCOM · shares +29% · price +7.7% | 0.58% | $374.9M | +$20.8M | ||||||||
| Bristol Myers Squibb CoCOM · shares +211% · price −16.3% | 0.58% | $374.4M | −$23.4M | ||||||||
| Shire PlcSPONSORED ADR · shares +128% · price −4.0% | 0.56% | $362.1M | −$6.6M | ||||||||
| Visa Inc.COM CL A · shares +1.1% · price −12.1% | 0.54% | $343.1M | −$46.7M | ||||||||
| Citigroup IncCOM NEW · shares +20% · price −27.4% | 0.48% | $310.9M | −$98.0M | ||||||||
| AlphabetCAP STK CL C · shares +189% · price −13.2% | 0.48% | $308.1M | −$16.3M | ||||||||
| Honeywell TechnologiesCOM · shares +150% · price −20.6% | 0.45% | $290.7M | −$30.2M | ||||||||
| Red Hat IncCOM · shares +293% · price +28.9% | 0.43% | $277.6M | +$15.8M | ||||||||
| Intercontinental Exchange InCOM · shares +153% · price +0.6% | 0.43% | $276.8M | +$638,224 | ||||||||
| IntelCOM · shares +857% · price −0.8% | 0.43% | $275.2M | −$220,758 | ||||||||
| Gilead Sciences IncCOM · shares +148% · price −19.0% | 0.42% | $269.9M | −$25.5M | ||||||||
| MastercardCL A · shares +673% · price −15.3% | 0.41% | $264.3M | −$6.2M | ||||||||
| TeslaCOM · shares +45,828% · price +25.8% | 0.41% | $261.2M | +$116,756 | ||||||||
| Lowes Cos IncCOM · shares +62% · price −19.6% | 0.40% | $259.5M | −$38.9M | ||||||||
| Twenty First Centy Fox IncCL A · shares +27% · price +3.9% | 0.40% | $256.7M | +$7.5M | ||||||||
| Csx CorpCOM · shares −33% · price −16.1% | 0.40% | $254.6M | −$48.8M | ||||||||
| Cvs Health CorpCOM · shares +595% · price −16.8% | 0.39% | $252.8M | −$7.3M | ||||||||
| Wells Fargo Co NewCOM · shares +20% · price −12.3% | 0.39% | $248.5M | −$29.0M | ||||||||
| Booking Hldgs IncCOM · shares +2,012% · price −13.2% | 0.39% | $248.4M | −$1.8M | ||||||||
| Total · 3,693 positions | 100% | $64.13B | −$7.52B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 2,753 stocks held throughout, down $7.52B (−17.0%).
- Eqt Corp19:1 split+$105.8M+711%
- Northern Oil & Gas Inc Nev100:1 split+$24.6M+5,550%
- Block4:1 split+$23.6M+127%
- Deciphera Pharmaceuticals In15:1 split+$22.9M+713%
- Merck & Co Inc+$20.8M+8%
- Citigroup Inc−$98.0M−27%
- Sm Energy Co−$100.6M−51%
- Marathon Oil Corp−$105.4M−38%
- Altaba Inc−$118.4M−15%
- Apple−$223.1M−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 33 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $276.29B+15% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $240.29B+1% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $237.79B+1% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $234.29B+13% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $207.08B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $187.88B−8% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $204.64B−3% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $210.88B−2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $215.93B−8% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $234.10B+1% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $231.13B+17% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $198.14B−2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $202.79B+16% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $174.39B−4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $180.74B+7% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $169.10B+5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $161.19B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $188.64B−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $196.76B+18% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $166.71B+2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $163.01B+17% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $139.75B+1% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $138.49B+71% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $81.22B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $72.98B+64% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $44.50B−44% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $79.93B+26% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $63.26B−5% | SEC ↗ |
| Q2 2019 | Aug 15, 2019 (amended) | $66.52B−0% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $66.82B+4% | SEC ↗ |
| Q4 2018 | Feb 15, 2019 (amended) | $64.13B−21% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $81.59B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $76.66B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $74.94B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $72.45B+10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $65.63B+17% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $56.06B+3% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $54.58B+14% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $47.75B−20% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $59.64B+37% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $43.69B+9% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $40.01B | SEC ↗ |